Development and Validation of an 18F-FDG PET/CT-based Radiomics Nomogram for Predicting the Prognosis of Patients with Esophageal Squamous Cell Carcinoma

Acad Radiol. 2024 Dec;31(12):5066-5077. doi: 10.1016/j.acra.2024.05.029. Epub 2024 Jun 6.

Abstract

Rationale and objectives: The aim of this study was to develop and validate a nomogram, integrating clinical factors and radiomics features, capable of predicting overall survival (OS) in patients diagnosed with esophageal squamous cell carcinoma (ESCC).

Methods: In this study, we retrospectively analyzed the case data of 130 patients with ESCC who underwent 18F-FDG PET/CT before treatment. Radiomics features associated with OS were screened by univariate Cox regression (p < 0.05). Further selection was performed by applying the least absolute shrinkage and selection operator Cox regression to generate the weighted Radiomics-score (Rad-score). Independent clinical risk factors were obtained by multivariate Cox regression, and a nomogram was constructed by combining Rad-score and independent risk factors. The predictive performance of the model for OS was assessed using the time-dependent receiver operating characteristic curve, concordance index (C-index), calibration curve, and decision curve analysis.

Results: Five radiomics features associated with prognosis were finally screened, and a Rad-score was established. Multivariate Cox regression analysis revealed that surgery and clinical M stage were identified as independent risk factors for OS in ESCC. The combined clinical-radiomics nomogram exhibited C-index values of 0.768 (95% CI: 0.699-0.837) and 0.809 (95% CI: 0.695-0.923) in the training and validation cohorts, respectively. Ultimately, calibration curves and decision curves for the 1-, 2-, and 3-year OS demonstrated the satisfactory prognostic prediction and clinical utility of the nomogram.

Conclusion: The developed nomogram, leveraging 18F-FDG PET/CT radiomics and clinically independent risk factors, demonstrates a reliable prognostic prediction for patients with ESCC, potentially serving as a valuable tool for guiding and optimizing clinical treatment decisions in the future.

Keywords: (18)F-FDG PET/CT; Esophageal cancer; Nomogram; Overall survival; Radiomics.

Publication types

  • Validation Study

MeSH terms

  • Adult
  • Aged
  • Esophageal Neoplasms* / diagnostic imaging
  • Esophageal Squamous Cell Carcinoma* / diagnostic imaging
  • Female
  • Fluorodeoxyglucose F18*
  • Humans
  • Male
  • Middle Aged
  • Nomograms*
  • Positron Emission Tomography Computed Tomography* / methods
  • Prognosis
  • Radiomics
  • Radiopharmaceuticals*
  • Retrospective Studies
  • Risk Factors

Substances

  • Fluorodeoxyglucose F18
  • Radiopharmaceuticals